ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 69 filers reported holding ARCELLX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,098,719 | -27.1% | 643,777 | -35.8% | 2.13% | -39.5% |
Q2 2023 | $31,683,208 | -17.6% | 1,001,999 | -19.7% | 3.52% | -11.6% |
Q1 2023 | $38,455,409 | +12.6% | 1,248,147 | +13.2% | 3.98% | -18.7% |
Q4 2022 | $34,153,808 | +46.8% | 1,102,447 | -11.1% | 4.90% | +55.0% |
Q3 2022 | $23,273,000 | +41.5% | 1,239,913 | +36.3% | 3.16% | +23.2% |
Q2 2022 | $16,448,000 | +18.5% | 909,739 | -8.1% | 2.57% | +43.4% |
Q1 2022 | $13,876,000 | – | 989,739 | – | 1.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $170,390,217 | 62.20% |
PATHWAY CAPITAL MANAGEMENT, LP | 189,120 | $5,858,938 | 10.46% |
NEA Management Company, LLC | 4,745,262 | $147,008,217 | 8.26% |
Samsara BioCapital, LLC | 957,451 | $29,661,832 | 6.38% |
Soleus Capital Management, L.P. | 1,102,447 | $34,153,808 | 4.90% |
Cormorant Asset Management, LP | 2,075,000 | $64,284 | 4.30% |
Paradigm Biocapital Advisors LP | 882,101 | $27,327,489 | 3.21% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,350,333 | $72,813,316 | 3.06% |
Affinity Asset Advisors, LLC | 240,143 | $7,439,630 | 2.92% |
CAXTON CORP | 36,302 | $1,124,640 | 2.87% |